Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
JLL Partners
JLL Receives Favorable Resolution of OSC Process; OSC Dismisses Special Committee Petition Seeking to Block the Offer; Bid to Proceed With Extended Expiry Time
May 3rd, 2009
JLL Partners, Inc. and its affiliate, JLL Patheon Holdings, LLC (collectively, "JLL"), announced that they have received a favorable resolution of the proceedings before the Ontario Securities Commission (the "OSC") relating to JLL's offer to purchase any and all of the issued and outstanding Restricted Voting Shares of Patheon Inc. ("Patheon") (TSX: PTI) for U.S. $2.00 cash per Restricted Voting Share (the "Offer"). At a hearing before the OSC held on April 16, 2009, the OSC dismissed the application by the Special Committee of the Patheon Board of Directors seeking to prevent the Offer from going forward. As previously announced, the Special Committee commenced a...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-03)
|
